4//SEC Filing
HENRY CHRISTIAN O 4
Accession 0001193125-25-314740
CIK 0001631574other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 9:45 PM ET
Size
20.6 KB
Accession
0001193125-25-314740
Insider Transaction Report
Form 4
HENRY CHRISTIAN O
Director
Transactions
- Sale
Ordinary Shares
2025-12-08$12.75/sh−6,445$82,174→ 12,700 total - Exercise/Conversion
Ordinary Shares
2025-12-08$5.97/sh+42,000$250,740→ 54,700 total - Sale
Ordinary Shares
2025-12-08$12.75/sh−42,000$535,500→ 12,700 total - Exercise/Conversion
Ordinary Shares
2025-12-08$3.50/sh+15,000$52,500→ 27,700 total - Sale
Ordinary Shares
2025-12-08$14.07/sh−15,000$211,050→ 12,700 total - Exercise/Conversion
Ordinary Shares
2025-12-08$4.58/sh+30,000$137,550→ 42,700 total - Sale
Ordinary Shares
2025-12-08$18.02/sh−30,000$540,600→ 12,700 total - Exercise/Conversion
Share Option (right to buy)
2025-12-08−42,000→ 0 totalExercise: $5.97Exp: 2026-08-16→ Ordinary Shares (42,000 underlying) - Exercise/Conversion
Share Option (right to buy)
2025-12-08−15,000→ 6,000 totalExercise: $3.50Exp: 2027-08-15→ Ordinary Shares (15,000 underlying) - Exercise/Conversion
Share Option (right to buy)
2025-12-08−30,000→ 15,000 totalExercise: $4.58Exp: 2028-08-07→ Ordinary Shares (30,000 underlying)
Footnotes (4)
- [F1]The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025.
- [F2]These share options are fully vested.
- [F3]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $14.00 to $14.14 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F4]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $18.00 to $18.19 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001263805
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 9:45 PM ET
- Size
- 20.6 KB